dTree : delivering dollar diagnostics

dTree is a low-cost molecular diagnostic device that is capable of producing a visible result in less than 60 minutes without any instrumentation.

dTree has been clinically validated with patient saliva samples for detecting SARS-CoV-2 virus during the COVID-19 pandemic. dTree was designed as a platform technology that can be adapted for diagnosing other diseases. Currently, dTree is being tested for diagnosing Schistosomiasis (via urine samples), a neglected-tropical diseases causing over 200,000 deaths/year with 700 million people living in endemic areas.